Overview of computational vaccinology: vaccine development through information technology

Journal of Applied Genetics

Volumn 56, Issue 3, 2015, Pages 381-391

  Vaishnav, Nishita ^a   Gupta, Aparna ^a   Paul, Sneha ^a,b   John, Georrge J ^a,c  

^a Christ College   (India)

^b CENTENNIAL COLLEGE   (Canada)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

In silico; Infection; Prediction; Vaccine

Indexed keywords

DNA VACCINE; EPITOPE; FREUND ADJUVANT; INACTIVATED VACCINE; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; MURAMYL DIPEPTIDE; RECOMBINANT VACCINE; SUBUNIT VACCINE; TETANUS TOXOID; TOXOID; IMMUNOLOGICAL ADJUVANT; VACCINE;

ANTIGEN BINDING; BIOINFORMATICS; CELLULAR IMMUNITY; COMPUTATIONAL VACCINOLOGY; DRUG DESIGN; GENE EXPRESSION; GENETIC ALGORITHM; GENETIC DATABASE; HOST PATHOGEN INTERACTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; INFORMATION TECHNOLOGY; NONHUMAN; PROTEIN STRUCTURE; REVIEW; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; BIOLOGY; CHEMISTRY; FACTUAL DATABASE;

ADJUVANTS, IMMUNOLOGIC; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; VACCINES;

EID: 84939652185     PISSN: 12341983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13353-014-0265-2     Document Type: Review

References (86)

1. Alexandersen S (1996) Advantages and disadvantages of using live vaccines risks and control measures. Acta Vet Scand 90:89–100
2. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403–410. doi:10.1016/S0022-2836(05)80360-2
3. André FE (2003) Vaccinology: past achievements, present roadblocks and future promises. Vaccine 21(7–8):593–5
4. Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:195–201. doi:10.1093/bioinformatics/bti770
5. Bambini S, Rappuoli R (2009) The use of genomics in microbial vaccine development. Drug Discov Today 14:252–260. doi:10.1016/j.drudis.2008.12.007
6. Case DA et al (2005) The amber biomolecular simulation programs. J Comput Chem 26:1668–1688. doi:10.1002/jcc.20290
7. Clem AS (2011) Fundamentals of vaccine immunology. J Glob Infect Dis 3(1):73–8. doi:10.4103/0974-777X.77299
8. Comeau SR, Gatchell DW, Vajda S, Camacho CJ (2004) ClusPro: a fully automated algorithm for protein-protein docking. Nucleic Acids Res 32:W96–99. doi:10.1093/nar/gkh354
9. Cox JC, Coulter AR (1997) Adjuvants–a classification and review of their modes of action. Vaccine 15(3):248–56
10. de Groot AS, Sbai H, Aubin CS, McMurry J, Martin W (2002) Immuno-informatics: mining genomes for vaccine components. Immunol Cell Biol 80:255–269. doi:10.1046/j.1440-1711.2002.01092.x
11. Donnelly JJ, Wahren B, Liu MA (2005) DNA vaccines: progress and challenges. J Immunol 175(2):633–9
12. Doytchinova IA, Flower DR (2007) VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinforma 8:4
13. El-Manzalawy Y, Dobbs D, Honavar V (2008) Predicting linear B-cell epitopes using string kernels. J Mol Recognit: JMR 21:243–255. doi:10.1002/jmr.893
14. Faldella G, Alessandroni R, Magini GM et al (1998) The preterm infant’s antibody response to a combined diphtheria, tetanus, acellular pertussis and hepatitis B vaccine. Vaccine 16(17):1646–9
15. Foged C (2011) Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems. Ther Deliv 2(8):1057–77
16. Fu L, Niu B, Zhu Z, Wu S, Li W (2012) CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics 28:3150–3152. doi:10.1093/bioinformatics/bts565
17. Giannini SL, Hanon E, Moris P et al (2006) Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only. Vaccine 24(33–34):5937–49
18. Glavaš G (2014) Front-end for Molecular dynamics (FeMD). http://www.globulus.net/femd/. Accessed 18 January 2014
19. Gough J, Karplus K, Hughey R, Chothia C (2001) Assignment of homology to genome sequences using a library of hidden Markov models that represent all proteins of known structure. J Mol Biol 313:903–919. doi:10.1006/jmbi.2001.5080
20. Hardy DJ (2014) MDAPI, Molecular Dynamics Applications Programming Interface;. http://www.ks.uiuc.edu/Development/MDTools/mdapi/. Accessed 18 January 2014
21. He Y (2014) Vaccine adjuvant informatics: from data integration and analysis to rational vaccine adjuvant design. Front Immunol 5:32. doi:10.3389/fimmu.2014.00032
22. He Y, Rappuoli R, de Groot AS, Chen RT (2010a) Emerging vaccine informatics. J Biomed Biotechnol 2010:218590. doi:10.1155/2010/218590
23. He Y, Xiang Z, Mobley HL (2010b) Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J Biomed Biotechnol 2010:297505. doi:10.1155/2010/297505
24. Herbert A (2014) MaxCluster: A tool for Protein Structure Comparison and Clustering. http://www.sbg.bio.ic.ac.uk/~maxcluster/. Accessed 5 January 2014
25. Huang Y, Niu B, Gao Y, Fu L, Li W (2010) CD-HIT Suite: a web server for clustering and comparing biological sequences. Bioinformatics 26(5):680–2. doi:10.1093/bioinformatics/btq003
26. Immunization (2014) http://pathmicro.med.sc.edu/ghaffar/immunization-ver2.htm. Accessed 18 January 2014
27. Isticato R, Cangiano G, Tran HT, Ciabattini A et al (2011) Surface display of recombinant proteins on Bacillus subtilis spores. J Bacteriol 183(21):6294–301
28. Iwanicki A, Piątek I, Stasiłojć M et al (2014) A system of vectors for Bacillus subtilis spore surface display. Microbiol Cell Fact 13(1):30. doi:10.1186/1475-2859-13-30
29. Jay P (2014) TINKER Molecular Modeling. http://dasher.wustl.edu/ffe. Accessed 30 March 2014
30. Jayaram B, Dhingra P, Lakhani B, Shekhar S (2012) Bhageerath—Targeting the near impossible: pushing the frontiers of atomic models for protein tertiary structure prediction. J Chem Sci 124:83–91. doi:10.1007/s12039-011-0189-x
31. Jefferys BR, Kelley LA (2010) Sternberg MJ. Protein folding requires crowd control in a simulated cell. J Mol Biol 397(5):1329–38. doi:10.1016/j.jmb.2010.01.074
32. John L, John GJ, Kholia T (2012) A reverse vaccinology approach for the identification of potential vaccine candidates from Leishmania spp. Appl Biochem Biotechnol 167:1340–1350. doi:10.1007/s12010-012-9649-0
33. Justin G (2014) Mindy - A ‘minimal’ molecular dynamics program. http://www.ks.uiuc.edu/Development/MDTools/mindy/. Accessed 18 January 2014
34. Kallberg M, Wang H, Wang S, Peng J, Wang Z, Lu H, Xu J (2012) Template-based protein structure modeling using the RaptorX web server. Nat Protoc 7:1511–1522. doi:10.1038/nprot.2012.085
35. Kelley LA, Sternberg MJ (2009) Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4:363–371. doi:10.1038/nprot.2009.2
36. Krieger E, Koraimann G, Vriend G (2002) Increasing the precision of comparative models with YASARA NOVA–a self-parameterizing force field. Proteins 47:393–402
37. Kronman MP, Zaoutis TE, Haynes K, Feng R, Coffin SE (2012) Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics 130:e794–803. doi:10.1542/peds. 2011-3886
38. Li W, Jaroszewski L, Godzik A (2001) Clustering of highly homologous sequences to reduce the size of large protein databases. Bioinformatics 17(3):282–3
39. Magrane M, Consortium U (2011) UniProt Knowledgebase: a hub of integrated protein data. Database (Oxford). 2011:bar009. doi: 10.1093/database/bar009.Print 2011
40. Major M, Moss S, Gold R (2011) From genes to vaccine: a breakthrough in the prevention of meningococcal group B disease. Paediatr Child Health 16:e61–64
41. Marciani DJ (2003) Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity. Drug Discov Today 8(20):934–943
42. Mayrose I et al (2007) Pepitope: epitope mapping from affinity-selected peptides. Bioinformatics 23:3244–3246. doi:10.1093/bioinformatics/btm493
43. McDowall MD, Scott MS, Barton GJ (2009) PIPs: human protein-protein interaction prediction database. Nucleic Acids Res 37:D651–656. doi:10.1093/nar/gkn870
44. Nebeker JR, Barach P, Samore MH (2004) Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting. Ann Intern Med 140:795–801
45. Nielsen M, Lundegaard C, Lund O, Kesmir C (2005) The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 57:33–41. doi:10.1007/s00251-005-0781-7
46. Nielsen M, Lundegaard C, Lund O, Petersen TN (2010) CPHmodels-3.0–remote homology modeling using structure-guided sequence profiles. Nucleic Acids Res 38:W576–581. doi:10.1093/nar/gkq535
47. NIAID NIoAaID (2013). http://www.niaid.nih.gov/topics/vaccines/Pages/Default.aspx. Accessed 27 December 2013
48. Ozgür A, Xiang Z, Radev DR, He Y (2011) Mining of vaccine-associated IFN-γ gene interaction networks using the Vaccine Ontology. J Biomed Semantics 17;2 Suppl 2:S8. doi:10.1186/2041-1480-2-S2-S8
49. Pande J, Szewczyk MM, Grover AK (2010) Phage display: concept, innovations, applications and future. Biotechnol Adv 28(6):849–58. doi:10.1016/j.biotechadv.2010.07.004
50. Petrovsky N, Aguilar JC (2004) Vaccine adjuvants: current state and future trends. Immunol Cell Biol 82(5):488–496
51. Pitre S et al (2006) PIPE: a protein-protein interaction prediction engine based on the re-occurring short polypeptide sequences between known interacting protein pairs. BMC Bioinforma 7:365. doi:10.1186/1471-2105-7-365
52. Pizza M et al (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287:1816–1820
53. Plotkin SA (2003) Vaccines, vaccination, and vaccinology. J Infect Dis 187(9):1349–59
54. Plotkin SA (2005) Vaccines: past, present and future. Nat Med 11(4 Suppl):S5–11
55. Plotkin SA (2008) New vaccination strategies. Bull Acad Natl Med 192:511–518, discussion 518–519
56. Pluimers FH (2004) Foot-and-Mouth disease control using vaccination: the Dutch experience in 2001. Dev Biol (Basel) 119:41–9
57. Poland GA, Ovsyannikova IG, Jacobson RM (2008) Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther 8(11):1659–67. doi:10.1517/14712598.8.11.1659
58. Poppe WA (2001) Nitroimidazole-resistant vaginal trichomoniasis treated with paromomycin. Eur J Obstet Gynecol Reprod Biol 96:119–120
59. Prieto C, de las Rivas J (2006) APID: agile protein interaction dataanalyzer. Nucleic Acids Res 34:W298–302. doi:10.1093/nar/gkl128
60. Principles of Vaccination (2014) http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/prinvac.pdf. Accessed 18 January 2014
61. Rappuoli R (2000) Reverse vaccinology. Curr Opin Microbiol 3:445–450
62. Real-Chicharro A et al (2009) Protopia: a protein-protein interaction tool. BMC Bioinforma 10(Suppl 12):S17. doi:10.1186/1471-2105-10-S12-S17
63. Robert E (2014) USEARCH: Ultra-fast Sequence analysis. http://drive5.com/usearch. Accessed 5 January 2014
64. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779–815. doi:10.1006/jmbi.1993.1626
65. Saxova P, Buus S, Brunak S, Kesmir C (2003) Predicting proteasomal cleavage sites: a comparison of available methods. Int Immunol 15:781–787
66. Sayers S, Ulysse G et al (2012) Vaxjo: a web-based vaccine adjuvant database and its application for analysis of vaccine adjuvants and their uses in vaccine development. J Biomed Biotechnol 2012:831486. doi:10.1155/2012/831486
67. Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2005) PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res 33:W363–367. doi:10.1093/nar/gki481
68. Serruto D, Serino L, Masignani V, Pizza M (2009) Genome-based approaches to develop vaccines against bacterial pathogens. Vaccine 27:3245–3250. doi:10.1016/j.vaccine.2009.01.072
69. Sibley L, Reljic R, Radford DS, Huang JM, Hong HA, Cranenburgh RM (2014) Cutting SM.Recombinant Bacillus subtilis spores expressing MPT64 evaluated as a vaccine against tuberculosis in the murine model. FEMS Microbiol Lett 358(2):170–9. doi:10.1111/1574-6968.12525
70. Singh H, Raghava GP (2001) ProPred: prediction of HLA-DR binding sites. Bioinformatics 17:1236–1237
71. Singh H, Raghava GP (2003) ProPred1: prediction of promiscuous MHC Class-I binding sites. Bioinformatics 19:1009–1014
72. Sinha JK & Bhattacharya S (2014) A Text Book of Immunology (Google Book Preview). Academic Publishers. p. 318. ISBN 978-81-89781-09-5. Retrieved 2014-01-09
73. Soding J (2005) Protein homology detection by HMM-HMM comparison. Bioinformatics 21:951–960. doi:10.1093/bioinformatics/bti125
74. Söding J (2005) Protein homology detection by HMM-HMM comparison. Bioinformatics 21(7):951–60
75. Sonnhammer EL, von Heijne G, Krogh A (1998) A hidden Markov model for predicting transmembrane helices in protein sequences. Proc / Int Conf Intell Sys Mol Biol; ISMB Int Conf Intell Sys Mol Biol 6:175–182
76. Sood S, Arti K (2008) An update on Trichomonas vaginalis. Indian J Sex Transm Dis 29:7–14
77. Thevenet P, Shen Y, Maupetit J, Guyon F, Derreumaux P, Tuffery P (2012) PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides. Nucleic Acids Res 40:W288–293. doi:10.1093/nar/gks419
78. van Duin D, Medzhitov R, Shaw AC (2006) Triggering TLR signaling in vaccination. Trends Immunol 27(1):49–55
79. van Houten NE, Henry KA, Smith GP, Scott JK (2010) Engineering filamentous phage carriers to improve focusing of antibody responses against peptides. Vaccine 28(10):2174–85. doi:10.1016/j.vaccine.2009.12.059
80. Vriend G (1990) WHAT IF: a molecular modeling and drug design program. J Mol Graph 8:52–56
81. WHO (2014) Tropical Disease Research (TDR). http://www.who.int/tdr/en/. Accessed 10 January 2014
82. Xiang Z, Todd T, Ku KP, Kovacic BL et al. (2008) VIOLIN: Vaccine Investigation and Online Information Network. Nucleic Acids Res 36(Database issue):D923-8
83. Xu D, Zhang Y (2012) Ab initio protein structure assembly using continuous structure fragments and optimized knowledge-based force field. Proteins 80:1715–1735. doi:10.1002/prot.24065
84. Yu CS, Lin CJ, Hwang JK (2004) Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n-peptide compositions. Protein Sci: a Publ Protein Soc 13:1402–1406. doi:10.1110/ps.03479604
85. Yu NY et al (2010) PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 26:1608–1615. doi:10.1093/bioinformatics/btq249
86. Zhang Y (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinforma 9:40. doi:10.1186/1471-2105-9-40